DMT-N4-Acetyl-2'-Deoxycytidine is a protected nucleoside derivative used as a building block in oligonucleotide synthesis. Its structure includes a 4,4'-dimethoxytrityl (DMT) protecting group and an N4-acetyl modification on the cytosine base, along with a free 3'-hydroxyl group for chain elongation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 100898-63-3
5'-O-Dimethoxytrityl-N-benzoyl-desoxycytidine
pharmaceutical intermediate
N-Acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluorocytidine
pharmaceutical intermediate
N-Acetyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-methylcytidine
pharmaceutical intermediate
N-[9-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-6-oxo-1H-purin-2-yl]-2-phenylacetamide
pharmaceutical intermediate
N4-Ac-C-(S)-GNA phosphoramidite
pharmaceutical intermediate
Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-, 2'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]purin-6-yl]benzamide
pharmaceutical intermediate
2-Benzylpropionic acid
pharmaceutical intermediate
N-[1-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
FHZQVUQHQIUSPM-PKZQBKLLSA-N
CC(=O)NC1=NC(=O)N(C=C1)[C@H]2C[C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O